Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(29%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
14%
Ph not_applicable
3
43%
Ph phase_3
1
14%
Ph phase_4
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(2)
Other(1)

Detailed Status

Completed2
Not yet recruiting2
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A3 (50.0%)

Trials by Status

completed229%
not_yet_recruiting229%
recruiting229%
unknown114%

Recent Activity

2 active trials
Showing 5 of 7
not_yet_recruitingphase_3

HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)

NCT07379190
recruiting

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

NCT05646394
completedphase_4

Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting

NCT05380063
completedphase_2

Anti-Platelets in Chronic Obstructive Pulmonary Disease

NCT05567562
recruitingnot_applicable

Stent-Assisted Coiling Followed by Ticagrelor Monotherapy Instead of Dual Antiplatelet Therapy in Unruptured Intracranial Aneurysm

NCT06015477
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07379190Phase 3

HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)

Not Yet Recruiting
NCT05646394

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Recruiting
NCT05380063Phase 4

Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting

Completed
NCT05567562Phase 2

Anti-Platelets in Chronic Obstructive Pulmonary Disease

Completed
NCT06015477Not Applicable

Stent-Assisted Coiling Followed by Ticagrelor Monotherapy Instead of Dual Antiplatelet Therapy in Unruptured Intracranial Aneurysm

Recruiting
NCT04995159Not Applicable

Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

Not Yet Recruiting
NCT02303717Not Applicable

Xience Versus Synergy in Left Main PCI

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7